Mechanism of mitochondria-induced proteostatic signaling and progressive muscle atrophy during aging.
衰老过程中线粒体诱导的蛋白质抑制信号传导和进行性肌肉萎缩的机制。
基本信息
- 批准号:10825174
- 负责人:
- 金额:$ 5.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-14 至 2027-09-13
- 项目状态:未结题
- 来源:
- 关键词:AblationAcuteAdenine Nucleotide TranslocaseAffectAgingAmino AcidsApoptosisAttenuatedAutophagocytosisBiochemicalBioenergeticsBiological AssayCell DeathCell Death InductionCessation of lifeChronicClinicalCytosolDataDefectDiseaseDual-Energy X-Ray AbsorptiometryEquilibriumFellowshipGoalsHistologicInner mitochondrial membraneKnowledgeMass Spectrum AnalysisMeasurementMediatingMembrane ProteinsMitochondriaMitochondrial DiseasesMitochondrial ProteinsMolecularMorbidity - disease rateMusMuscleMuscular AtrophyMyopathyNADHOxidation-ReductionOxidative PhosphorylationOxidative StressPathway interactionsPatientsPeptide HydrolasesPhosphorylationPhosphotransferasesPlayProcessProductionProtein BiosynthesisProtein ImportProteinsQuality of lifeReactive Oxygen SpeciesRepressionRespirationRoleSLC25A4 geneScanningSignal TransductionSkeletal MuscleStarvationStressStress Response SignalingTestingTissuesTransgenic MiceTranslationsagedbiological adaptation to stressin vivoinsightmitochondrial dysfunctionmortalitymouse modelmulticatalytic endopeptidase complexmuscle agingmuscle formmuscle stressnovelnovel therapeuticsoverexpressionpreservationprotein degradationproteostasisresponsesarcopeniaskeletal muscle wastingstressortranscriptome sequencingwasting
项目摘要
Muscle atrophy (or wasting) is defined by reduced myofiber size and number, which increases morbidity and
mortality and decreases quality of life. One of the mechanisms of muscle atrophy is the loss of proteostatic
balance. When protein degradation exceeds synthesis, protein content is decreased to reduce myofiber size
and muscle mass. How the balance between protein synthesis and degradation is disturbed in diseased and
aged skeletal muscle in unknown. Mitochondrial dysfunction plays an important role in skeletal muscle atrophy
under many disease conditions and during normative aging, with the underlying mechanism remaining poorly
understood. Perturbations in oxidative phosphorylation and the subsequent increase in reactive oxygen
species production, collectively termed “bioenergetic defects”, have been proposed to drive muscle loss.
However, accumulating evidence suggests that substantial levels of bioenergetic deficiency and oxidative
stress are insufficient to cause muscle wasting. Therefore, if mitochondrial dysfunction does indeed result in
muscle loss, it may involve bioenergetically independent factors. The Chen lab recently found that various
forms of mitochondrial damage can reduce mitochondrial protein import. This causes proteostatic stress in the
cytosol, termed mitochondrial Precursor Overaccumulation Stress (mPOS), followed by global remodeling of
proteostasis. We recently generated a transgenic mouse line that moderately overexpresses the mitochondrial
inner membrane protein, Ant1. We found that Ant1-induced mitochondrial protein import stress causes
progressive muscle atrophy, accompanied by reduction of mitochondrial respiration. However, whether muscle
atrophy is caused by bioenergetic deficiency or bioenergetic-independent stressors remains unknown.
Interestingly, RNA-seq analysis revealed a robust activation of the integrated stress response (ISR), which in
turn represses global protein synthesis and activates autophagy. ISR activation is commonly found in tissues
derived from patients with mitochondrial disease. Using this unique mouse model, we propose to determine the
molecular mechanisms of mitochondria-induced muscle atrophy and ISR activation. In Aim 1, we will determine
the mechanism by which mitochondrial protein import stress induces muscle wasting. In Aim 2, we will
determine whether ISR activation protects skeletal muscle from myofiber death and myopathy in the setting of
mPOS. The long-term goal of this project is to understand how bioenergetics-independent mitochondrial stress
signaling promotes chronic muscle wasting in normative and non-normative aging. The results of this
application may help establish a bioenergetics-independent pathway for treating mitochondria-induced muscle
disease and possibly sarcopenia.
肌肉萎缩(或消瘦)的定义是肌纤维大小和数量的减少,这增加了发病率和发病率
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicholas Brennan其他文献
Nicholas Brennan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 5.27万 - 项目类别:
Standard Grant














{{item.name}}会员




